Cervical Cancer Trial, Recruiting NCT06618703 Sponsor: University Hospital, Angers Condition: Cervical Cancer
Back to Cervical Cancer

Cervical Cancer Trial, Recruiting

NCT06618703
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and young people aged 4 years old or older, but younger than 18 years old, at the time of joining the trial
  • People who received radiation therapy to part or all of the brain for cancer or a blood cancer before the age of 16
  • People for whom the radiation therapy finished 5 years ago or less
  • People whose cancer is in remission after completing all cancer treatments, or whose disease has been stable without any treatment for 2 or more years
  • People whose parent or legal guardian has signed a consent form agreeing to participation
  • People who are covered by the French social security system (or an equivalent)

Who may not be able to join:

  • People whose cancer has come back, or who have developed a second cancer, within less than 1 year after finishing treatment
  • People who are receiving palliative (end-of-life comfort) care
  • People whose radiation treatment records show that a specific area of the brain involved in hormone regulation (the hypothalamic-pituitary axis) received a very low radiation dose, suggesting it was largely protected
  • People who had a known hormone problem related to the hypothalamic-pituitary area of the brain before receiving radiation therapy
  • People where the child or their parents have said they do not want to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0241353565

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Angers
Registry
ClinicalTrials.gov
Start date
10 October 2025
Est. completion
1 October 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Endocrine toxicities assessment after radiotherapy involving all or part of the brain in children, adolescents and young adults treated for cancer before the age of 16 (≤15 years)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov